PUBPOL 5113

Last Updated

  • Schedule of Classes - September 10, 2024 10:17AM EDT
  • Course Catalog - September 10, 2024 9:48AM EDT
Global toggle of class tabs

Links for textbooks and Cornell Store open in new tab.

PUBPOL 5113
Key Management Issues in the Biotech and Pharmaceutical Industries

Course information provided by the Courses of Study 2024-2025. Courses of Study 2024-2025 is scheduled to publish mid-June.

This course provides an overview of the key management issues facing the pharmaceutical and biotechnology industries. The emphasis is on the United States because it is the largest and most profitable market, but we will briefly cover issues affecting global markets.

When Offered Fall.

Permission Note Enrollment limited to: Sloan Executive Master of Health Administration (EMHA) students.

Outcomes
  • Through this course, students will learn to analyze how decisions made throughout drug testing and development impact a drug's performance over its lifecycle.
  • Describe how firms set prices and negotiate with health insurers.
  • Anticipate the pros and cons of a merger, acquisition, or alliance opportunity.
  • Deconstruct and critique drug marketing strategies.

View Enrollment Information

Syllabi: none

  •   Seven Week - First. 

  • 1 Credit Graded

  • 12990 PUBPOL 5113   LEC 001

  •  
    • MW TBA
    • Aug 26 - Oct 11, 2024

    • Nicholson, S

  • Instruction Mode: Distance Learning-Synchronous